img

Global Seasonal Influenza Vaccines Therapeutics Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Seasonal Influenza Vaccines Therapeutics Market Insights, Forecast to 2034

Seasonal influenza vaccines are medical products used to prevent influenza virus infection and reduce the severity of flu symptoms during flu seasons.
Market Analysis and InsightsGlobal Seasonal Influenza Vaccines Therapeutics Market
Global Seasonal Influenza Vaccines Therapeutics market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, Seasonal Influenza Vaccines Therapeutics industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
The market for seasonal influenza vaccines is driven by the demand for preventive healthcare measures and the need to reduce the burden of seasonal flu on healthcare systems. The market's growth is also influenced by the growing emphasis on vaccination and immunization programs globally.
Report Covers
This report presents an overview of global Seasonal Influenza Vaccines Therapeutics market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Seasonal Influenza Vaccines Therapeutics market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


GSK
Novartis
CSL
MedImmune
Sanofi-Pasteur
Solvay
Hualan Biological Engineering
Sinovac Biotech
Changchun Institute of Biological Products Co., Ltd.
Shanghai Institute of Biological Products Co., Ltd.
Segment by Type
Paediatrics
Adolescence
Adults
Elderly

Segment by Application


Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Seasonal Influenza Vaccines Therapeutics introduction, etc. Seasonal Influenza Vaccines Therapeutics Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Seasonal Influenza Vaccines Therapeutics
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Seasonal Influenza Vaccines Therapeutics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Paediatrics
1.2.3 Adolescence
1.2.4 Adults
1.2.5 Elderly
1.3 Market by Application
1.3.1 Global Seasonal Influenza Vaccines Therapeutics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Seasonal Influenza Vaccines Therapeutics Market Perspective (2018-2029)
2.2 Global Seasonal Influenza Vaccines Therapeutics Growth Trends by Region
2.2.1 Seasonal Influenza Vaccines Therapeutics Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Seasonal Influenza Vaccines Therapeutics Historic Market Size by Region (2018-2024)
2.2.3 Seasonal Influenza Vaccines Therapeutics Forecasted Market Size by Region (2024-2029)
2.3 Seasonal Influenza Vaccines Therapeutics Market Dynamics
2.3.1 Seasonal Influenza Vaccines Therapeutics Industry Trends
2.3.2 Seasonal Influenza Vaccines Therapeutics Market Drivers
2.3.3 Seasonal Influenza Vaccines Therapeutics Market Challenges
2.3.4 Seasonal Influenza Vaccines Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Seasonal Influenza Vaccines Therapeutics by Players
3.1.1 Global Seasonal Influenza Vaccines Therapeutics Revenue by Players (2018-2024)
3.1.2 Global Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Players (2018-2024)
3.2 Global Seasonal Influenza Vaccines Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Seasonal Influenza Vaccines Therapeutics, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Seasonal Influenza Vaccines Therapeutics Market Concentration Ratio
3.4.1 Global Seasonal Influenza Vaccines Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Seasonal Influenza Vaccines Therapeutics Revenue in 2022
3.5 Global Key Players of Seasonal Influenza Vaccines Therapeutics Head office and Area Served
3.6 Global Key Players of Seasonal Influenza Vaccines Therapeutics, Product and Application
3.7 Global Key Players of Seasonal Influenza Vaccines Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Seasonal Influenza Vaccines Therapeutics Breakdown Data by Type
4.1 Global Seasonal Influenza Vaccines Therapeutics Historic Market Size by Type (2018-2024)
4.2 Global Seasonal Influenza Vaccines Therapeutics Forecasted Market Size by Type (2024-2029)
5 Seasonal Influenza Vaccines Therapeutics Breakdown Data by Application
5.1 Global Seasonal Influenza Vaccines Therapeutics Historic Market Size by Application (2018-2024)
5.2 Global Seasonal Influenza Vaccines Therapeutics Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Seasonal Influenza Vaccines Therapeutics Market Size (2018-2029)
6.2 North America Seasonal Influenza Vaccines Therapeutics Market Size by Type
6.2.1 North America Seasonal Influenza Vaccines Therapeutics Market Size by Type (2018-2024)
6.2.2 North America Seasonal Influenza Vaccines Therapeutics Market Size by Type (2024-2029)
6.2.3 North America Seasonal Influenza Vaccines Therapeutics Market Share by Type (2018-2029)
6.3 North America Seasonal Influenza Vaccines Therapeutics Market Size by Application
6.3.1 North America Seasonal Influenza Vaccines Therapeutics Market Size by Application (2018-2024)
6.3.2 North America Seasonal Influenza Vaccines Therapeutics Market Size by Application (2024-2029)
6.3.3 North America Seasonal Influenza Vaccines Therapeutics Market Share by Application (2018-2029)
6.4 North America Seasonal Influenza Vaccines Therapeutics Market Size by Country
6.4.1 North America Seasonal Influenza Vaccines Therapeutics Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Seasonal Influenza Vaccines Therapeutics Market Size by Country (2018-2024)
6.4.3 North America Seasonal Influenza Vaccines Therapeutics Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Seasonal Influenza Vaccines Therapeutics Market Size (2018-2029)
7.2 Europe Seasonal Influenza Vaccines Therapeutics Market Size by Type
7.2.1 Europe Seasonal Influenza Vaccines Therapeutics Market Size by Type (2018-2024)
7.2.2 Europe Seasonal Influenza Vaccines Therapeutics Market Size by Type (2024-2029)
7.2.3 Europe Seasonal Influenza Vaccines Therapeutics Market Share by Type (2018-2029)
7.3 Europe Seasonal Influenza Vaccines Therapeutics Market Size by Application
7.3.1 Europe Seasonal Influenza Vaccines Therapeutics Market Size by Application (2018-2024)
7.3.2 Europe Seasonal Influenza Vaccines Therapeutics Market Size by Application (2024-2029)
7.3.3 Europe Seasonal Influenza Vaccines Therapeutics Market Share by Application (2018-2029)
7.4 Europe Seasonal Influenza Vaccines Therapeutics Market Size by Country
7.4.1 Europe Seasonal Influenza Vaccines Therapeutics Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Seasonal Influenza Vaccines Therapeutics Market Size by Country (2018-2024)
7.4.3 Europe Seasonal Influenza Vaccines Therapeutics Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Seasonal Influenza Vaccines Therapeutics Market Size (2018-2029)
8.2 China Seasonal Influenza Vaccines Therapeutics Market Size by Type
8.2.1 China Seasonal Influenza Vaccines Therapeutics Market Size by Type (2018-2024)
8.2.2 China Seasonal Influenza Vaccines Therapeutics Market Size by Type (2024-2029)
8.2.3 China Seasonal Influenza Vaccines Therapeutics Market Share by Type (2018-2029)
8.3 China Seasonal Influenza Vaccines Therapeutics Market Size by Application
8.3.1 China Seasonal Influenza Vaccines Therapeutics Market Size by Application (2018-2024)
8.3.2 China Seasonal Influenza Vaccines Therapeutics Market Size by Application (2024-2029)
8.3.3 China Seasonal Influenza Vaccines Therapeutics Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Seasonal Influenza Vaccines Therapeutics Market Size (2018-2029)
9.2 Asia Seasonal Influenza Vaccines Therapeutics Market Size by Type
9.2.1 Asia Seasonal Influenza Vaccines Therapeutics Market Size by Type (2018-2024)
9.2.2 Asia Seasonal Influenza Vaccines Therapeutics Market Size by Type (2024-2029)
9.2.3 Asia Seasonal Influenza Vaccines Therapeutics Market Share by Type (2018-2029)
9.3 Asia Seasonal Influenza Vaccines Therapeutics Market Size by Application
9.3.1 Asia Seasonal Influenza Vaccines Therapeutics Market Size by Application (2018-2024)
9.3.2 Asia Seasonal Influenza Vaccines Therapeutics Market Size by Application (2024-2029)
9.3.3 Asia Seasonal Influenza Vaccines Therapeutics Market Share by Application (2018-2029)
9.4 Asia Seasonal Influenza Vaccines Therapeutics Market Size by Region
9.4.1 Asia Seasonal Influenza Vaccines Therapeutics Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Seasonal Influenza Vaccines Therapeutics Market Size by Region (2018-2024)
9.4.3 Asia Seasonal Influenza Vaccines Therapeutics Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Seasonal Influenza Vaccines Therapeutics Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Type
10.2.1 Middle East, Africa, and Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Seasonal Influenza Vaccines Therapeutics Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Application
10.3.1 Middle East, Africa, and Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Seasonal Influenza Vaccines Therapeutics Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Country
10.4.1 Middle East, Africa, and Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Details
11.1.2 GSK Business Overview
11.1.3 GSK Seasonal Influenza Vaccines Therapeutics Introduction
11.1.4 GSK Revenue in Seasonal Influenza Vaccines Therapeutics Business (2018-2024)
11.1.5 GSK Recent Developments
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Seasonal Influenza Vaccines Therapeutics Introduction
11.2.4 Novartis Revenue in Seasonal Influenza Vaccines Therapeutics Business (2018-2024)
11.2.5 Novartis Recent Developments
11.3 CSL
11.3.1 CSL Company Details
11.3.2 CSL Business Overview
11.3.3 CSL Seasonal Influenza Vaccines Therapeutics Introduction
11.3.4 CSL Revenue in Seasonal Influenza Vaccines Therapeutics Business (2018-2024)
11.3.5 CSL Recent Developments
11.4 MedImmune
11.4.1 MedImmune Company Details
11.4.2 MedImmune Business Overview
11.4.3 MedImmune Seasonal Influenza Vaccines Therapeutics Introduction
11.4.4 MedImmune Revenue in Seasonal Influenza Vaccines Therapeutics Business (2018-2024)
11.4.5 MedImmune Recent Developments
11.5 Sanofi-Pasteur
11.5.1 Sanofi-Pasteur Company Details
11.5.2 Sanofi-Pasteur Business Overview
11.5.3 Sanofi-Pasteur Seasonal Influenza Vaccines Therapeutics Introduction
11.5.4 Sanofi-Pasteur Revenue in Seasonal Influenza Vaccines Therapeutics Business (2018-2024)
11.5.5 Sanofi-Pasteur Recent Developments
11.6 Solvay
11.6.1 Solvay Company Details
11.6.2 Solvay Business Overview
11.6.3 Solvay Seasonal Influenza Vaccines Therapeutics Introduction
11.6.4 Solvay Revenue in Seasonal Influenza Vaccines Therapeutics Business (2018-2024)
11.6.5 Solvay Recent Developments
11.7 Hualan Biological Engineering
11.7.1 Hualan Biological Engineering Company Details
11.7.2 Hualan Biological Engineering Business Overview
11.7.3 Hualan Biological Engineering Seasonal Influenza Vaccines Therapeutics Introduction
11.7.4 Hualan Biological Engineering Revenue in Seasonal Influenza Vaccines Therapeutics Business (2018-2024)
11.7.5 Hualan Biological Engineering Recent Developments
11.8 Sinovac Biotech
11.8.1 Sinovac Biotech Company Details
11.8.2 Sinovac Biotech Business Overview
11.8.3 Sinovac Biotech Seasonal Influenza Vaccines Therapeutics Introduction
11.8.4 Sinovac Biotech Revenue in Seasonal Influenza Vaccines Therapeutics Business (2018-2024)
11.8.5 Sinovac Biotech Recent Developments
11.9 Changchun Institute of Biological Products Co., Ltd.
11.9.1 Changchun Institute of Biological Products Co., Ltd. Company Details
11.9.2 Changchun Institute of Biological Products Co., Ltd. Business Overview
11.9.3 Changchun Institute of Biological Products Co., Ltd. Seasonal Influenza Vaccines Therapeutics Introduction
11.9.4 Changchun Institute of Biological Products Co., Ltd. Revenue in Seasonal Influenza Vaccines Therapeutics Business (2018-2024)
11.9.5 Changchun Institute of Biological Products Co., Ltd. Recent Developments
11.10 Shanghai Institute of Biological Products Co., Ltd.
11.10.1 Shanghai Institute of Biological Products Co., Ltd. Company Details
11.10.2 Shanghai Institute of Biological Products Co., Ltd. Business Overview
11.10.3 Shanghai Institute of Biological Products Co., Ltd. Seasonal Influenza Vaccines Therapeutics Introduction
11.10.4 Shanghai Institute of Biological Products Co., Ltd. Revenue in Seasonal Influenza Vaccines Therapeutics Business (2018-2024)
11.10.5 Shanghai Institute of Biological Products Co., Ltd. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Seasonal Influenza Vaccines Therapeutics Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Paediatrics
Table 3. Key Players of Adolescence
Table 4. Key Players of Adults
Table 5. Key Players of Elderly
Table 6. Global Seasonal Influenza Vaccines Therapeutics Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 7. Global Seasonal Influenza Vaccines Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Seasonal Influenza Vaccines Therapeutics Market Size by Region (2018-2024) & (US$ Million)
Table 9. Global Seasonal Influenza Vaccines Therapeutics Market Share by Region (2018-2024)
Table 10. Global Seasonal Influenza Vaccines Therapeutics Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Seasonal Influenza Vaccines Therapeutics Market Share by Region (2024-2029)
Table 12. Seasonal Influenza Vaccines Therapeutics Market Trends
Table 13. Seasonal Influenza Vaccines Therapeutics Market Drivers
Table 14. Seasonal Influenza Vaccines Therapeutics Market Challenges
Table 15. Seasonal Influenza Vaccines Therapeutics Market Restraints
Table 16. Global Seasonal Influenza Vaccines Therapeutics Revenue by Players (2018-2024) & (US$ Million)
Table 17. Global Seasonal Influenza Vaccines Therapeutics Revenue Share by Players (2018-2024)
Table 18. Global Top Seasonal Influenza Vaccines Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Seasonal Influenza Vaccines Therapeutics as of 2022)
Table 19. Global Seasonal Influenza Vaccines Therapeutics Industry Ranking 2021 VS 2022 VS 2024
Table 20. Global 5 Largest Players Market Share by Seasonal Influenza Vaccines Therapeutics Revenue (CR5 and HHI) & (2018-2024)
Table 21. Global Key Players of Seasonal Influenza Vaccines Therapeutics, Headquarters and Area Served
Table 22. Global Key Players of Seasonal Influenza Vaccines Therapeutics, Product and Application
Table 23. Global Key Players of Seasonal Influenza Vaccines Therapeutics, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Seasonal Influenza Vaccines Therapeutics Market Size by Type (2018-2024) & (US$ Million)
Table 26. Global Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Type (2018-2024)
Table 27. Global Seasonal Influenza Vaccines Therapeutics Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Seasonal Influenza Vaccines Therapeutics Revenue Market Share by Type (2024-2029)
Table 29. Global Seasonal Influenza Vaccines Therapeutics Market Size by Application (2018-2024) & (US$ Million)
Table 30. Global Seasonal Influenza Vaccines Therapeutics Revenue Share by Application (2018-2024)
Table 31. Global Seasonal Influenza Vaccines Therapeutics Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Seasonal Influenza Vaccines Therapeutics Revenue Share by Application (2024-2029)
Table 33. North America Seasonal Influenza Vaccines Therapeutics Market Size by Type (2018-2024) & (US$ Million)
Table 34. North America Seasonal Influenza Vaccines Therapeutics Market Size by Type (2024-2029) & (US$ Million)
Table 35. North America Seasonal Influenza Vaccines Therapeutics Market Size by Application (2018-2024) & (US$ Million)
Table 36. North America Seasonal Influenza Vaccines Therapeutics Market Size by Application (2024-2029) & (US$ Million)
Table 37. North America Seasonal Influenza Vaccines Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. North America Seasonal Influenza Vaccines Therapeutics Market Size by Country (2018-2024) & (US$ Million)
Table 39. North America Seasonal Influenza Vaccines Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 40. Europe Seasonal Influenza Vaccines Therapeutics Market Size by Type (2018-2024) & (US$ Million)
Table 41. Europe Seasonal Influenza Vaccines Therapeutics Market Size by Type (2024-2029) & (US$ Million)
Table 42. Europe Seasonal Influenza Vaccines Therapeutics Market Size by Application (2018-2024) & (US$ Million)
Table 43. Europe Seasonal Influenza Vaccines Therapeutics Market Size by Application (2024-2029) & (US$ Million)
Table 44. Europe Seasonal Influenza Vaccines Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Europe Seasonal Influenza Vaccines Therapeutics Market Size by Country (2018-2024) & (US$ Million)
Table 46. Europe Seasonal Influenza Vaccines Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 47. China Seasonal Influenza Vaccines Therapeutics Market Size by Type (2018-2024) & (US$ Million)
Table 48. China Seasonal Influenza Vaccines Therapeutics Market Size by Type (2024-2029) & (US$ Million)
Table 49. China Seasonal Influenza Vaccines Therapeutics Market Size by Application (2018-2024) & (US$ Million)
Table 50. China Seasonal Influenza Vaccines Therapeutics Market Size by Application (2024-2029) & (US$ Million)
Table 51. Asia Seasonal Influenza Vaccines Therapeutics Market Size by Type (2018-2024) & (US$ Million)
Table 52. Asia Seasonal Influenza Vaccines Therapeutics Market Size by Type (2024-2029) & (US$ Million)
Table 53. Asia Seasonal Influenza Vaccines Therapeutics Market Size by Application (2018-2024) & (US$ Million)
Table 54. Asia Seasonal Influenza Vaccines Therapeutics Market Size by Application (2024-2029) & (US$ Million)
Table 55. Asia Seasonal Influenza Vaccines Therapeutics Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 56. Asia Seasonal Influenza Vaccines Therapeutics Market Size by Region (2018-2024) & (US$ Million)
Table 57. Asia Seasonal Influenza Vaccines Therapeutics Market Size by Region (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Type (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Type (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Application (2018-2024) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Application (2024-2029) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Seasonal Influenza Vaccines Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 63. Middle East, Africa, and Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Country (2018-2024) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Seasonal Influenza Vaccines Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 65. GSK Company Details
Table 66. GSK Business Overview
Table 67. GSK Seasonal Influenza Vaccines Therapeutics Product
Table 68. GSK Revenue in Seasonal Influenza Vaccines Therapeutics Business (2018-2024) & (US$ Million)
Table 69. GSK Recent Developments
Table 70. Novartis Company Details
Table 71. Novartis Business Overview
Table 72. Novartis Seasonal Influenza Vaccines Therapeutics Product
Table 73. Novartis Revenue in Seasonal Influenza Vaccines Therapeutics Business (2018-2024) & (US$ Million)
Table 74. Novartis Recent Developments
Table 75. CSL Company Details
Table 76. CSL Business Overview
Table 77. CSL Seasonal Influenza Vaccines Therapeutics Product
Table 78. CSL Revenue in Seasonal Influenza Vaccines Therapeutics Business (2018-2024) & (US$ Million)
Table 79. CSL Recent Developments
Table 80. MedImmune Company Details
Table 81. MedImmune Business Overview
Table 82. MedImmune Seasonal Influenza Vaccines Therapeutics Product
Table 83. MedImmune Revenue in Seasonal Influenza Vaccines Therapeutics Business (2018-2024) & (US$ Million)
Table 84. MedImmune Recent Developments
Table 85. Sanofi-Pasteur Company Details
Table 86. Sanofi-Pasteur Business Overview
Table 87. Sanofi-Pasteur Seasonal Influenza Vaccines Therapeutics Product
Table 88. Sanofi-Pasteur Revenue in Seasonal Influenza Vaccines Therapeutics Business (2018-2024) & (US$ Million)
Table 89. Sanofi-Pasteur Recent Developments
Table 90. Solvay Company Details
Table 91. Solvay Business Overview
Table 92. Solvay Seasonal Influenza Vaccines Therapeutics Product
Table 93. Solvay Revenue in Seasonal Influenza Vaccines Therapeutics Business (2018-2024) & (US$ Million)
Table 94. Solvay Recent Developments
Table 95. Hualan Biological Engineering Company Details
Table 96. Hualan Biological Engineering Business Overview
Table 97. Hualan Biological Engineering Seasonal Influenza Vaccines Therapeutics Product
Table 98. Hualan Biological Engineering Revenue in Seasonal Influenza Vaccines Therapeutics Business (2018-2024) & (US$ Million)
Table 99. Hualan Biological Engineering Recent Developments
Table 100. Sinovac Biotech Company Details
Table 101. Sinovac Biotech Business Overview
Table 102. Sinovac Biotech Seasonal Influenza Vaccines Therapeutics Product
Table 103. Sinovac Biotech Revenue in Seasonal Influenza Vaccines Therapeutics Business (2018-2024) & (US$ Million)
Table 104. Sinovac Biotech Recent Developments
Table 105. Changchun Institute of Biological Products Co., Ltd. Company Details
Table 106. Changchun Institute of Biological Products Co., Ltd. Business Overview
Table 107. Changchun Institute of Biological Products Co., Ltd. Seasonal Influenza Vaccines Therapeutics Product
Table 108. Changchun Institute of Biological Products Co., Ltd. Revenue in Seasonal Influenza Vaccines Therapeutics Business (2018-2024) & (US$ Million)
Table 109. Changchun Institute of Biological Products Co., Ltd. Recent Developments
Table 110. Shanghai Institute of Biological Products Co., Ltd. Company Details
Table 111. Shanghai Institute of Biological Products Co., Ltd. Business Overview
Table 112. Shanghai Institute of Biological Products Co., Ltd. Seasonal Influenza Vaccines Therapeutics Product
Table 113. Shanghai Institute of Biological Products Co., Ltd. Revenue in Seasonal Influenza Vaccines Therapeutics Business (2018-2024) & (US$ Million)
Table 114. Shanghai Institute of Biological Products Co., Ltd. Recent Developments
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Seasonal Influenza Vaccines Therapeutics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Seasonal Influenza Vaccines Therapeutics Market Share by Type: 2022 VS 2029
Figure 3. Paediatrics Features
Figure 4. Adolescence Features
Figure 5. Adults Features
Figure 6. Elderly Features
Figure 7. Global Seasonal Influenza Vaccines Therapeutics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Seasonal Influenza Vaccines Therapeutics Market Share by Application: 2022 VS 2029
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Others Case Studies
Figure 12. Seasonal Influenza Vaccines Therapeutics Report Years Considered
Figure 13. Global Seasonal Influenza Vaccines Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Seasonal Influenza Vaccines Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Seasonal Influenza Vaccines Therapeutics Market Share by Region: 2022 VS 2029
Figure 16. Global Seasonal Influenza Vaccines Therapeutics Market Share by Players in 2022
Figure 17. Global Top Seasonal Influenza Vaccines Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Seasonal Influenza Vaccines Therapeutics as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Seasonal Influenza Vaccines Therapeutics Revenue in 2022
Figure 19. North America Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Seasonal Influenza Vaccines Therapeutics Market Share by Type (2018-2029)
Figure 21. North America Seasonal Influenza Vaccines Therapeutics Market Share by Application (2018-2029)
Figure 22. North America Seasonal Influenza Vaccines Therapeutics Market Share by Country (2018-2029)
Figure 23. United States Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Seasonal Influenza Vaccines Therapeutics Market Size YoY (2018-2029) & (US$ Million)
Figure 26. Europe Seasonal Influenza Vaccines Therapeutics Market Share by Type (2018-2029)
Figure 27. Europe Seasonal Influenza Vaccines Therapeutics Market Share by Application (2018-2029)
Figure 28. Europe Seasonal Influenza Vaccines Therapeutics Market Share by Country (2018-2029)
Figure 29. Germany Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. France Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. U.K. Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Italy Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Russia Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Nordic Countries Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. China Seasonal Influenza Vaccines Therapeutics Market Size YoY (2018-2029) & (US$ Million)
Figure 36. China Seasonal Influenza Vaccines Therapeutics Market Share by Type (2018-2029)
Figure 37. China Seasonal Influenza Vaccines Therapeutics Market Share by Application (2018-2029)
Figure 38. Asia Seasonal Influenza Vaccines Therapeutics Market Size YoY (2018-2029) & (US$ Million)
Figure 39. Asia Seasonal Influenza Vaccines Therapeutics Market Share by Type (2018-2029)
Figure 40. Asia Seasonal Influenza Vaccines Therapeutics Market Share by Application (2018-2029)
Figure 41. Asia Seasonal Influenza Vaccines Therapeutics Market Share by Region (2018-2029)
Figure 42. Japan Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. South Korea Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. China Taiwan Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Southeast Asia Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. India Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Australia Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Seasonal Influenza Vaccines Therapeutics Market Size YoY (2018-2029) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Seasonal Influenza Vaccines Therapeutics Market Share by Type (2018-2029)
Figure 50. Middle East, Africa, and Latin America Seasonal Influenza Vaccines Therapeutics Market Share by Application (2018-2029)
Figure 51. Middle East, Africa, and Latin America Seasonal Influenza Vaccines Therapeutics Market Share by Country (2018-2029)
Figure 52. Brazil Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Mexico Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Turkey Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Saudi Arabia Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Israel Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. GCC Countries Seasonal Influenza Vaccines Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. GSK Revenue Growth Rate in Seasonal Influenza Vaccines Therapeutics Business (2018-2024)
Figure 59. Novartis Revenue Growth Rate in Seasonal Influenza Vaccines Therapeutics Business (2018-2024)
Figure 60. CSL Revenue Growth Rate in Seasonal Influenza Vaccines Therapeutics Business (2018-2024)
Figure 61. MedImmune Revenue Growth Rate in Seasonal Influenza Vaccines Therapeutics Business (2018-2024)
Figure 62. Sanofi-Pasteur Revenue Growth Rate in Seasonal Influenza Vaccines Therapeutics Business (2018-2024)
Figure 63. Solvay Revenue Growth Rate in Seasonal Influenza Vaccines Therapeutics Business (2018-2024)
Figure 64. Hualan Biological Engineering Revenue Growth Rate in Seasonal Influenza Vaccines Therapeutics Business (2018-2024)
Figure 65. Sinovac Biotech Revenue Growth Rate in Seasonal Influenza Vaccines Therapeutics Business (2018-2024)
Figure 66. Changchun Institute of Biological Products Co., Ltd. Revenue Growth Rate in Seasonal Influenza Vaccines Therapeutics Business (2018-2024)
Figure 67. Shanghai Institute of Biological Products Co., Ltd. Revenue Growth Rate in Seasonal Influenza Vaccines Therapeutics Business (2018-2024)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries